Molina Healthcare (NYSE:MOH) Announces FY 2026 Earnings Guidance

Molina Healthcare (NYSE:MOH) issued an update on its FY 2026 earnings guidance on Friday. The company provided earnings per share (EPS) guidance of 5.250- for the period, compared to the consensus EPS estimate of 5.260.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on MOH shares. Wall Street Zen upgraded shares of Molina Healthcare from a “sell” rating to a “hold” rating in a research report on Saturday. Jefferies Financial Group restated a “hold” rating and set a $220.00 price target on shares of Molina Healthcare in a report on Friday. Zacks Research downgraded Molina Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Monday, October 12th. Truist Financial decreased their price target on shares of Molina Healthcare from $250.00 to $225.00 and set a “hold” rating for the company in a report on Friday, July 24th. Finally, Robert W. Baird set a $198.00 price objective on shares of Molina Healthcare in a report on Friday. Three analysts have rated the stock with a Buy rating, thirteen have given a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $209.62.

Molina Healthcare Trading Down 3.5%

Shares of MOH stock traded down $7.68 during trading hours on Friday, reaching $208.96. The company had a trading volume of 1,265,851 shares, compared to its average volume of 831,603. Molina Healthcare has a 1-year low of $121.06 and a 1-year high of $244.89. The company has a 50 day moving average of $200.65 and a 200 day moving average of $196.15. The company has a debt-to-equity ratio of 0.95, a current ratio of 1.69 and a quick ratio of 1.68. The firm has a market cap of $10.91 billion, a price-to-earnings ratio of -217.66, a P/E/G ratio of 31.26 and a beta of 0.78.

Molina Healthcare (NYSE:MOH) last posted its earnings results on Wednesday, October 21st. The company reported $0.89 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.79 by $0.10. Molina Healthcare had a positive return on equity of 2.50% and a negative net margin of 0.11%. The company had revenue of $11.08 billion during the quarter, compared to analyst estimates of $10.86 billion. During the same period in the previous year, the company earned $1.84 EPS. The company’s revenue for the quarter was down 3.4% compared to the same quarter last year. On average, equities research analysts anticipate that Molina Healthcare will post 5.25 EPS for the current year.

Molina Healthcare News Roundup

Here are the key news stories impacting Molina Healthcare this week:

• Positive Sentiment: Third-quarter adjusted EPS came in at $0.89, ahead of estimates, while revenue of $11.08 billion also exceeded expectations. The company reaffirmed its broader outlook, supporting confidence that Medicaid margins are stabilizing. Molina Surpasses Q3 Earnings and Revenue Estimates
• Positive Sentiment: Management outlined at least $45 billion of premium revenue for 2027, while its earnings “building blocks” totaled more than $9.50 per share. The outlook suggests potential for growth from premium expansion, Medicaid rate increases and improved margins. Molina Outlines 2027 Premium and EPS Outlook
• Positive Sentiment: Bank of America Securities maintained a Buy rating on MOH, indicating that some analysts view the recent weakness as an opportunity despite near-term cost pressures. Bank of America Maintains Buy Rating
• Neutral Sentiment: Molina updated fiscal 2026 EPS guidance to approximately $5.25, broadly in line with the $5.26 consensus estimate. The limited change reduces the likelihood of a major earnings-estimate reset but offers little new upside catalyst.
• Neutral Sentiment: Analyst opinion remains divided: Morgan Stanley raised its price target from $167 to $192 but retained an Equal Weight rating, while other coverage remains more constructive. Morgan Stanley Raises Molina Price Target
• Negative Sentiment: Net income fell sharply year over year to about $38 million, and revenue declined 3.4% from the prior-year quarter. Earnings also dropped from $1.84 per share a year earlier, highlighting continued profitability pressure despite the quarterly beat. Molina Reports Q3 Net Income Decline
• Negative Sentiment: Membership shrinkage, elevated medical costs and uncertainty around Medicaid rate timing remain key risks. Morgan Stanley’s target is below the current trading level, reinforcing valuation concerns and helping explain the pressure on MOH shares.

About Molina Healthcare

Molina Healthcare, Inc is a managed-care company that provides health insurance and related services primarily through government-sponsored programs. Its offerings include Medicaid, Medicare, Medicare-Medicaid dual-eligible plans and health plans sold through government marketplaces under the Affordable Care Act.

The company’s services generally include medical care coordination, behavioral health support, pharmacy benefits and, depending on the plan and state, dental and vision benefits.